1st-line treatment with BR and FCR in patients with chronic lymphocytic leukamia. 6. Juni 2014 Knauf, W., Abenhardt, W., Engel, E., Grugel, R., Harde, J., Jänicke, M., Marschner, N., 2014. Oncol Res Treat 37 (suppl5)(P186), 50. doi:10.1159/000368945 Abstract Download Long-term side effects of curative treatment for breast cancer – data from the MaTox project. Hurtz, H.-J., Tesch, H., Göhler, T., Hutzschenreuter, U., Harde, J., Kruggel, L., Marschner, N., 2014. Oncol Res Treat 37 (suppl 5)(V370), 110. doi:10.1159/000368945… Weiterlesen Treatment of chemotherapy-induced neutropenia with Lipegfilgrastim (Lonquex®): First interim analysis of the non-interventional study NADIR. Kurbacher, C., Diel, I., Egert, M., Fietz, T., Hurtz, H., Lück, A., Weide, R., Wolff, T., Zaiss, M., Teichmann, B., Harde, J., Scheuerlein, R., 2014. Weiterlesen